The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Two news items from Bay Area life sciences tools startup Unchained Labs: It just announced a $25 million Series A, and acquired a multiplex stability platform for biologics called Optim that will ...
PLEASANTON, Calif., Jan. 13, 2025 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting biologics and gene therapy researchers the right tool for the job, launched Aunty ...
Carlyle Group has agreed to acquire Unchained Labs for $435 million in partnership with management. Exiting investors are Novo Holdings A/S, Canaan Partners and TPG Biotech. J.P. Morgan Securities ...
PLEASANTON, Calif., Feb. 9, 2022 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting biologics and gene therapy researchers the right tools for the job, announced the ...
AXT is excited to announce that they have partnered with Unchained Labs and will now be exclusively distributing their innovative and novel range of instruments for the analysis and formulation of ...
Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, acquired Blacktrace Holdings today. For decades, Blacktrace’s ...
Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, has now released its LEA 9 software, making Freeslate and Junior automation systems ...
PLEASANTON, Calif., July 17, 2023 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting biologics and gene therapy researchers the right tools for the job, acquired ...
Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, has now released its LEA 9 software, making Freeslate and Junior automation systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results